A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171
Clinical trial NCT02309320 · COMPLETED
Trial details
- NCT number
- NCT02309320
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.